Anesthetic drugs & techniques

Opioid-free versus opioid-based anesthesia for quality of recovery following laparoscopic hysterectomy: a randomized controlled non-inferiority trial

Anaesth Crit Care Pain MedPublished Randomised controlled trial

Primary result · QoR-15Result — go to the resultMedian difference 2.0 points 95% CI −1.0-4.0

Authors' conclusion

Opioid-free anesthesia demonstrated non-inferiority to opioid-based anesthesia for recovery quality while reducing the incidence and severity of PONV.

Study context

Population
Women (ASA I–II) undergoing elective laparoscopic hysterectomyall completed follow-up
Participants
110 women
Comparison
Opioid-free vs opioid-based GA
  • Opioid-freen = 55
  • Opioid-basedn = 55reference
Primary endpoint
Recovery quality (QoR-15)
Follow-up
24 h
Methodological detailsnon-inferiority, 96% protocol adherence
  • Non-inferiority
  • 96% protocol adherence

Primary result

QoR-15

Median difference

2.0 points

95% CI −1.0-4.0

P < 0.001

By group

Opioid-free

123

median · IQR 115–127

Opioid-based

121

median · IQR 114–125

Opioid-free vs Opioid-based
median difference 2.0 points (95% CI −1.0-4.0); P < 0.001

As reported in the abstract

Secondary outcomes

OutcomeOpioid-freeOpioid-basedEstimateP value
PONV incidence18.2%36.4%RR 0.50 (95% CI 0.26–0.97)P = 0.032
PONV severityOR 0.39 (95% CI 0.16–0.94)P = 0.035
OutcomeP value
Postoperative morphine consumptionComparable between groupsP = 0.315

Safety

No serious adverse events occurred

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Opioid-free versus opioid-based anesthesia for quality of recovery following laparoscopic hysterectomy: a randomized controlled non-inferiority trial. Anaesth Crit Care Pain Med. Published 20 March 2026. doi:10.1016/j.accpm.2026.101815

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.